SpaceX Is Quickly Entering Index Funds. Will OpenAI and Anthropic do the Same After Their IPOs?

SpaceX’s July 7 Nasdaq-100 inclusion could spur about $4.3B of passive buying, highlighting how Nasdaq’s new fast-entry rule may accelerate index fund demand for mega IPOs. The article notes OpenAI (filed for IPO, targeting ~$1T valuation) and Anthropic (raised $65B, valued ~$965B in May 2026) could also enter certain indexes quickly, but S&P 500 inclusion is likely slower due to a 12-month trading-history requirement and profitability screens. It also flags U.S. government ownership/foreign-access constraints as potential headwinds to IPO timing, valuation, and post-listing volatility, so index inclusion doesn’t remove business and valuation risk.

Analysis

The key edge here is not the IPO itself but the forced-buyer dynamics once a mega-cap listing becomes index-eligible. That creates a short-duration demand shock concentrated in the free float, which can push first-week performance well above what fundamentals justify; the size of the pop will be a function of listed shares, not headline valuation. For index infrastructure, the economic upside is mostly narrative value, but NDAQ has the cleanest benefit because the Nasdaq-100 can become the default benchmark for the next wave of elite AI listings.

Second-order, public AI model companies could siphon attention away from the compute stack and compress relative multiples in AI hardware/software names if investors decide they can own the “model” instead of the picks-and-shovels. That said, NVDA remains the structural winner if frontier labs keep scaling capex; the more relevant trade is whether public AI equity becomes a new quasi-defensive growth bucket that crowds capital out of existing software leaders over the next 6-18 months. JPM also benefits at the margin through IPO syndication and secondary distribution, but that’s a fee pool story, not a multi-quarter earnings inflection.

The contrarian miss is assuming fast index entry equals durable support. If S&P’s 12-month/profitability screen holds, the real catalyst migrates from passive buying to post-IPO earnings visibility, and that’s where these names remain vulnerable: valuation, dilution, and regulation can all overwhelm the initial technical bid. The key falsifiers are small float, delayed listing, or regulatory constraints that reduce eligible shares; in that case, the “index inclusion” thesis fades quickly and the stocks revert to being expensive, volatile growth assets rather than index darlings.

Key Decisions for Investors

• Long NDAQ / short SPGI for 1-3 months: express the view that Nasdaq’s faster inclusion regime monetizes the mega-IPO pipeline sooner than S&P’s slower gatekeeping; stop if SPGI begins to re-rate on rule-change expectations or if IPO timing slips.
• Buy SPCX on the first index-inclusion window and plan to sell into the passive bid over days, not months: this is a technical trade, not a quality call; invalidation is a larger-than-expected float or a weak lock-up setup that dilutes the squeeze.
• Use JPM as a low-beta hedgeable beneficiary into the IPO cycle, but keep sizing modest: upside is fee-volume optionality over the next 1-2 quarters, while downside is limited if listings stall.
• Avoid chasing NVDA on this headline alone; if anything, watch for relative underperformance versus AI-app/software baskets over 1-3 months as capital rotates toward public model exposure.
• Set an alert for any S&P profitability-rule exception or delay in IPO timing: if the fast-track narrative breaks, fade the benchmark-flow trade and expect the technical bid to unwind within weeks.